(NASDAQ: DTIL) Precision Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 27.06%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41.04%.
Precision Biosciences's earnings in 2025 is -$21,986,000.On average, 5 Wall Street analysts forecast DTIL's earnings for 2025 to be -$65,484,892, with the lowest DTIL earnings forecast at -$85,845,108, and the highest DTIL earnings forecast at -$53,206,891. On average, 5 Wall Street analysts forecast DTIL's earnings for 2026 to be -$20,584,198, with the lowest DTIL earnings forecast at -$54,658,341, and the highest DTIL earnings forecast at $5,472,043.
In 2027, DTIL is forecast to generate -$28,765,097 in earnings, with the lowest earnings forecast at -$53,897,688 and the highest earnings forecast at $10,827,661.